Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q4 2024 Earnings Call Transcript February 26, 2025
Madrigal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-2.71, expectations were $-4.32.
Operator: Good day, and thank you for standing by. Welcome to Madrigal Pharmaceuticals’ Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there’ll be a question-and-answer session. As a...
